When marketing promises a claim the formula can't support

It's one of the most common tensions in a supplement or functional-food business: marketing wants to say something bold and sellable, and the formula — or the regulation — won't back it up. The collision between what sells and what's true and legal is inevitable. What matters is catching it early, on the screen, rather than late, on a printed label. Here's why it happens and how to defuse it.

Where the collision comes from

Marketing works from the benefit a customer wants to hear; R&D works from what the formula actually delivers; regulatory works from what the market permits. These three don't automatically agree. A claim can be commercially perfect and still fail because the dose is below the threshold that supports it, or because the market doesn't allow that wording, or because a reformulation quietly made it ineligible. The claim isn't wrong out of carelessness — it's wrong because three teams optimised for three different things.

Why it surfaces too late

The damage is worst when the mismatch is found at the end — after artwork, after a print run, sometimes after launch. By then a claim the formula can't support means relabeling, withdrawn stock, or a regulatory query, all expensive and public. It surfaces late because in a manual process nothing connects the claim on the label to the dose in the formula and the rule in the market until a person happens to check.

Claims belong tied to the formula

The fix is to treat a claim as something anchored to the actives and amounts that justify it and the market that permits it — not as free text typed onto artwork. When a claim is linked to the dose that supports it, dropping that dose below threshold flags the claim; when it's checked against the market, an impermissible wording is caught. Marketing can then see what's actually supportable before committing to it.

Turning a fight into a conversation

When everyone can see, on the same formula, which claims the product supports and which markets allow them, the argument changes. Instead of marketing pushing and regulatory blocking after the fact, the team designs to the claim from the start — setting the dose to support the claim they want, or choosing a claim the formula already earns. The claim becomes a shared design target, not a late veto.

Where Lemoniq fits

Lemoniq keeps claims tied to the actives and amounts that support them and checks them against the markets you sell in — so an under-supported or impermissible claim is flagged while the formula is on the screen, not after the label is printed. Marketing, R&D, and regulatory work from the same view of what the product can legally and truthfully say.

The takeaway

Marketing promising a claim the formula can't support is a structural collision between three teams' goals — and it's ruinous when caught late. Anchoring claims to the dose that justifies them and the market that permits them turns the late veto into an early, shared design decision. Design to the claim; don't discover the gap at the printer.

Lemoniq shows what your formula can legally claim before the label is printed. See how it works